SEARCH

SEARCH BY CITATION

REFERENCES

  • Altland K, Kaempher M, Forssbohm M, Werner W. 1982. Monitoring for changing mutations rates using blood samples submitted for PKU screening. In: Bonne-TamirB, CohenT, GoodmanRM, editors. Human genetics, part A: the unfolding genome. New York: Alan R. Liss, Inc. pp 277287.
  • Anderson OA, Flatmark T. 2001. High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in the catalytically active Fe(II) form and binary complex with tetrahydrobiopterin. J Mol Biol 314:279291.
  • Anderson OA, Flatmark T, Hough E. 2002. Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine, and its implications for the mechanisms of catalysis and substrate activation. J Mol Biol 320:10951108.
  • Antonarakis SE, Krawczak M, Cooper DN. 2001. The nature and mechanisms of human gene mutation. In: ScriverCR, BeaudetAL, SlyWS, ValleD, ChildsB, KinzlerKW, VogelsteinB, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 343377.
  • Aulehla-Scholz C, Heilbronner H. 2003. Mutational spectrum in German patients with phenylalanine hydroxylase deficiency. Hum Mutat 21:399400.
  • Byck S, Morgan K, Tyfield L, Dworniczak B, Scriver CR. 1994. Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet 3:16751677.
  • Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285298.
  • Carter KC, Byck S, Waters PJ, Richards B, Nowacki PM, Laframboise R, Lambert M, Treacy E, Scriver CR. 1998. Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience. Eur J Hum Genet 6:6170.
  • Cavalli-Sforza LL, Piazza A. 1993. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1:318.
  • Chao HK, Hsiao KJ, Su, TS. 2001. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 108:1419.
  • Chen KJ, Chao HK, Hsiao KJ, Su TS. 2002. Identification and characterization of a novel liver-specific enhancer of the human phenylalanine hydroxylase gene. Hum Genet 110:235243.
  • Claustres M, Horaitis O, Vanevski M, Cotton RGH. 2002. Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases. Genome Res 12:680688.
  • Cotton RGH, Scriver CR. 1998. Proof of “disease-causing” mutation. Hum Mutat 12:13.
  • Desviat LR, Perez B, Gamez A, Sanchez A, Garcia MJ, Martinez-Padro M, Marchante C, Boveda D, Baldellou A, Arena J, Sanjurjo P, Fernandez A, Cabello ML, Ugarte M. 1999. Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions. Eur J Hum Genet 386392.
  • Eiken HG, Knappskog PM, Boman H, Thune KS, Kaada G, Motzfeldt K, Apold J. 1996. Relative frequency, heterogeneity and geographic clustering of PKU mutations in Norway. Eur J Hum Genet 4:205213.
  • Eisensmith RC, Goltzov AA, O'Neill C, Tyfield LA, Schwartz EI, Kuzmin AI, Baranovskaya SS, Tsukerman GL, Treacy E, Scriver CR, Guttler F, Gulberg P, Eiken HG, Apold J, Svensson E, Naughten E, Cahalane SF, Croke DT, Cockburn F, Woo SLC. 1995. Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans. Am J Hum Genet 56:278286.
  • Ellingsen S, Knappskog PM, Eiken HG. 1997. Phenylketonuria splice mutation (EXON6nt–96A>g) masquerading as missense mutation (Y204C). Hum Mutat 9:8890.
  • Ellingsen SP, Knappskog PM, Apold J, Eiken HG. 1999. Diverse PAH transcripts in lymphocytes of PKU patients with putative nonsense (G272X, Y356X) and missense (P281L, R408Q) mutations. FEBS Lett 457:505508.
  • Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens RC. 1997. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat Struct Biol 4:9951000.
  • Erlandsen H, Stevens RC. 1999. The structural basis of phenylketonuria. Mol Genet Metab 68:103125.
  • Erlandsen H, Bjorgo E, Flatmark T, Stevens RC. 2000. Crystal structure and site-specific mutagenesis of pterin-bound human phenylalanine hydroxylase. Biochemistry 39:22082217.
  • Erlandsen H, Stevens RC. 2001. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninemia and phenylketonuria. J Inherit Metab Dis 24:213230.
  • Fusetti F, Erlandsen H, Flatmark T, Stevens RC. 1998. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem 273:1696216967.
  • Gable M, Williams M, Stephenson A, Okano Y, Ring S, Hurtubise M, Tyfield L. 2003. Comparative multiplex dosage analysis detects whole exon deletions at the phenylalanine hydroxylase locus. Hum Mutat 21:379386.
  • Gamez A, Perez AB, Ugarte M, Desviat LR. 2000. Expression analysis of phenylketonuria mutations. J Biol Chem 275:2973729742.
  • Garrod AE. 1908. Inborn Errors of Metabolism. Oxford: Oxford University Press.
  • Gjetting T, Romstad A, Haavik J, Knappskog PM, Acosta AX, Silvia WA Jr, Zago MA, Guldberg P, Guttler F. 2001a. A phenylalanine hydroxylase amino acid polymorphism with implications for molecular diagnostics. Mol Genet Metab 73:280284.
  • Gjetting T, Petersen M, Guldberg P, Guttler F. 2001b. Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine. Am J Hum Genet 68:13531360.
  • Guldberg P, Henriksen KF, Guttler F. 1993a. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 17:141146.
  • Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A, Mollica F, Meli C, Giovannini M, Riva E, Biasucci G, Henricksen KF, Guttler F. 1993b. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily - Implications for diagnosis of hyperphenylalani-nemia in Southern Europe. Hum Mol Genet 2:17031707.
  • Guldberg P, Levy HL, Hanley WB, Koch R, Matalon R, Rouse BM, Trefz F, De la Cruz F, Henriksen KF, Guttler F. 1996. Phenylalanine hydroxylase gene mutations in the United States: report from the maternal PKU collaborative study. Am J Hum Genet 59:8494.
  • Guldberg P, Zschocke J, Dagbjartsson K, Friss Henrisksen K, Guttler F. 1997. A molecular survey of phenylketonuria in Iceland: identification of a founding mutation and evidence of predominant Norse settlement. Eur J Hum Genet 5:376381.
  • Guldberg P, Rey F, Zschocke J, Romano C, Francois B, Michiels L, Ullrich K, Hoffman GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Guttler F. 1998. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:7179.
  • Haefele MJ, White G, McDonald JD. 2001. Characterization of the mouse phenylalanine hydroxylase mutation Pahenu3. Mol Genet Metab 72:2730.
  • International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409:860921.
  • John SWM, Rozen R, Scriver CR, Laframboise R, Laberge C. 1990. Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet 46:970974.
  • Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR. 1997. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am J Hum Genet 61:13091317.
  • Keller M. 2002. Making sense of life. Explaining biological development with models, metaphors and machines. Cambridge, MA: Harvard University Press.
  • Kidd JR, Pakstis AJ, Zhao H, Lu RB, Okonofua E, Odunsi A, Frigorenko E, Bonne-Tamir B, Friedlaender J, Schulz LO, Parnas J, Kidd KK. 2000. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet 66:18821899.
  • Knappskog PM, Eiken HG, Martinez A, Bruland O, Apold J, Flatmark T. 1996. PKU mutation (D143G) associated with an apparent high residual enzyme activity: expression of a kinetic variant form of phenylalanine hydroxylase in three different systems. Hum Mutat 8:236246.
  • Kobe B, Jennings IG, House CM, Mitchell BJ, Goodwill KE, Santarsiero BD, Stevens RC, Cotton RGH, Kemp BE. 1999. Structural basis of autoregulation of phenylalanine. Nat Struct Biol 6:442448.
  • Konecki DS, Wang Y, Trefz FK, Lichter-Konecki U, Woo SLC. 1992. Structural characterization of the 5′ region of the human phenylalanine hydroxylase gene. Biochemistry 31:83638368.
  • Krawczak M, Zschocke J. 2003. A role for overdominant selection in phenylketonuria? Evidence from molecular data. Hum Mutat 21:394397.
  • Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, Sakamoto O, Fugii K, Matsubara Y, Narisawa K. 1999. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr 135:375378.
  • Kwok SCM, Ledley FD, Dilella AG, Robson KJH, Woo SLC. 1985. Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556561.
  • Leandro P, Rivera I, Lechner MC, Tavares de Almeida I, Konecki D. 2000. The V388M mutation results in a kinetic variant form of phenylalanine hydroxylase. Mol Genet Metab 69:204212.
  • Ledley FD, Grenett HE, Dunbar BS, Woo SLC. 1990. Mouse phenylalanine hydroxylase. Homology and divergence from human phenylalanine hydroxylase. Biochem J 267:399405.
  • Martinez A, Andersson KK, Haavik J, Flatmark T. 1991. EPR and 1H-NMR spectroscopic studies on the paramagnetic iron at the active site of phenylalanine hydroxylase and its interaction with substrates and inhibitors. Eur J Biochem 198:675682.
  • Martinez A, Knappskog PM, Olafsdottir S, Doskeland AP, Eiken HG, Svebak RM, Bozzini M, Apold J, Flatmark T. 1995. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Biochem J 306:589597.
  • Maurer SM, Firestone RB, Scriver CR. 2000. Science's neglected legacy. Nature 405:117120.
  • McDonald JD, Bode V, Dove W, Shedlovsky A. 1990. Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 87:19651967.
  • McDonald JD, Charlton CK. 1997. Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39:402405.
  • Okano Y, Eisensmith RC, Guttler F, Lichter-Konecki U, Konecki DS, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC. 1991. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:12321238.
  • Sarkissian C, Shao Z, Blain F, Peevres R, Su H, Heft R, Chang TMS, Scriver CR. 1999. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci USA 96:23392344.
  • Sarkissian C, Boulais DM, McDonald JD, Scriver CR. 2000. A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia. Mol Genet Metab 69:188194.
  • Scriver CR. 2001. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2:69101.
  • Scriver CR, Kaufman S. 2001. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: ScriverCR, BeaudetA, SlyWS, ValleD, ChildsB, KinzlerKW, VogelsteinB, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 16671724.
  • Scriver CR, Waters PJ. 1999. Monogenic traits are not simple. Lessons from phenylketonuria. Trends Genet 15:267272.
  • Scriver CR, Byck S, Prevost L, Hoang L, PAH Mutation Analysis Consortium. 1996. The phenylalanine hydroxylase locus: a marker for the history of phenylketonuria and human genetic diversity. In: Chadwick D, Cardew G, editors. Variation in the human genome. Ciba Foundation Symposium No 197. Chichester: John Wiley.
  • Scriver CR, Waters PJ, Sarkissian C, Ryan S, Prevost L, Cote D, Novak J, Teebi S, Nowacki PM. 2000. PAHdb: a locus-specific knowledgebase. Hum Mutat 15:99104.
  • Shedlovsky A, McDonald JD, Smyula D, Dove WF. 1993. Mouse models of human phenylketonuria. Genetics 134:12051210.
  • Sullivan SE, Lidsky AS, Brayton K, Dilella AG, King M, Connor M, Cockburn F, Woo SLC. 1985. Phenylalanine hydroxylase deletion mutant from a patient with classical PKU. Amer J Hum Genet 37:A177 (Abstract).
  • Svensson E, Wang Y, Eisensmith RC, Hagenfeldt L, Woo SLC. 1993. Three polymorphisms but no disease-causing mutations in the proximal part of the promotor of the phenylalanine hydroxylase gene. Eur J Hum Genet 1:306313.
  • Teebi SA, Porter CJ, Talbot CC Jr, Cuticchia AJ. 2001. The BiSC WayStation: a centralized structure for the collection of genetic variations. Am J Hum Genet 69:452 (Abstract 1581).
  • Teigen K, Froystein NA, Martinez A. 1999. The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism. J Mol Biol 294:807823.
  • Terp BN, Cooper DN, Christensen IT, Jorgensen FS, Bross P, Gregersen N, Krawczak M. 2002. Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic diseease. Hum Mutat 20:98109.
  • Tighe O, Dunican D, O'Neill C, Bertorelle D, Beattie D, Graham C, Zschocke J, Cali F, Romano V, Hrabincova E, Kozak L, Nechyporenko M, Livshits L, Guldberg P, Jurkowska M, Zekanowski C, Perez B, Ruiz Desviat L, Ugarte M, Kucinskas V, Knappskog P, Treacy E, Naughten E, Tyfield L, Byck S, Scriver CR, Mayne PD, Croke DT. 2003. Genetic diversity within the R408W phenylketonuria mutation lineages in Europe. Hum Mutat 21:387393.
  • Treacy E, Byck S, Clow C, Scriver CR. 1993. ‘Celtic’ phenylketonuria chromosomes found? Evidence in two regions of Quebec province. Eur J Hum Genet 1:220228.
  • Venter JC, Adams MD, Myers EW, et al. 2001. The sequence of the human genome. Science 291:13041351.
  • Waters PJ. 2003. How PAH gene mutations cause hyperphenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 21:357369.
  • Waters PJ, Parniak MA, Nowacki P, Scriver CR. 1998. In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function. Hum Mutat 11:1417.
  • Waters PJ, Parniak MA, Akerman BR, Scriver CR. 2000. Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype. Mol Genet Metab 69:101110. (Erratum in Mol Genet Metab 72:89.)
  • Weiss KM. 1996. Is there a paradigm shift in genetics? Lessons from the study of human diseases. Mol Phylogenet Evol 5:259265.
  • Zschocke J. 2003. Phenylketonuria mutations in Europe. Hum Mutat 21:345356.
  • Zschocke J, Hoffmann GF. 1999. Phenylketonuria mutations in Germany. Hum Genet 104:390398.
  • Zschocke J, Graham CA, Carson DJ, Nevin NC. 1995. Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach. Am J Hum Genet 57:13111317.
  • Zschocke J, Mallory JP, Eiken HS, Nevin NC. 1997. Phenylketonuria and the peoples of Northern Ireland. Hum Genet 100:189194.
  • Zschocke J, Quak E, Knauer A, Fritz B, Asselan M, Hoffmann GF. 1999. Large heterozygous deletion masquerading as homozygous missense mutation: a pitfall in diagnostic mutation analysis. J Inherit Metab Dis 22:687692.